UMIN-CTR History

Name:  UMIN ID:


Unique ID issued by UMIN UMIN000025452
Receipt number R000029240
Scientific Title Phase I clinical study of a WT1-W10 peptide immunotherapy combined with standard treatment against diffuse midline glioma (WT1-TR-DMG).
Date of disclosure of the study information 2017/01/04
Last modified on 2019/07/01 11:32:11

No. Disposal Last modified on Item of update
1 Insert 2016/12/28 09:41:18
2 Update 2019/07/01 11:32:11 Recruitment status
Date of IRB